CD79A and COVID-19: According to Huang et al. and Wu et al., IgM, IgA, and neutralizing IgG antibodies can be detected in 12, 14 and 10–14 days, respectively, after symptom onset on average, suggesting that SARS-CoV-2 causes a robust B cell response in the majority of COVID-19 patients (Wu F et al., 2020; Huang et al., 2020).